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Introduction
Only one family in Israel, from Ethiopian Jewish origin has
been diagnosed with the familial cold autoinflammatory
syndrome phenotype of the cryopyrin associated periodic
syndromes (CAPS)[1].
Case Report
We confirmed the Muckle-Wells syndrome phenotype of
CAPS by NLRP3 genetic testing in a three generation
family of Turkish Jewish origin, previously diagnosed with
familial Behcet disease due to the presence of mucosal
ulcers in several family members with the finding of the
HLA-B51 antigen in at least one family member. Eight
family members including a deceased grandfather, 4 of his
daughters and three grandchildren had brief episodes of
fever and chills, accompanied by headache, myalgia,
arthralgia, and an urticarial skin rash. Most family
members had substantial hearing loss. None developed
amyloidosis. Four family members tested for a NLRP3
pathogenic variant had the known NM_001243313.1:
c.1043C>T, p.Thr348Met variant[2]. Following initiation
of treatment with canakinumab (150 mg every 8 weeks)
and colchicine for mucosal ulcers all disease symptoms
resolved and acute phase reactants normalized except for
persistent headaches in one grandchild and tinitus in
another. The health-related quality of life of the treated
grandchildren markedly improved.
Discussion
NLRP3 genetic testing was instrumental in the diagnosis of
CAPS in this family, particularly as some family members
presented with atypical features suggestive of Behcet dis-
ease, which is much more common in Israel. Although
CAPS is a rare disease, additional cases with other NLRP3
variants may exist in Israel.
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